Lisata Therapeutics

LSTANasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$9.653 M

$1.06 -0.94%

Close of 7 Aug 2026

Revenue

$170.0K

#3596 by revenue

Earnings

-$16.6M

Loss-making

Shares outstanding

9,010,937

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#431Aspire BiopharmaASBP$10.0M
#432CytoMed TherapeuticsGDTC$9.71M
#433Lisata TherapeuticsLSTA$9.65M
#434Quoin PharmaceuticalsQNRX$9.62M
#435Lexaria BioscienceLEXX$8.71M

Where these numbers come from

Share counts and financials for Lisata Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.